Clorox (NYSE:CLX) Price Target Cut to $120.00 by Analysts at Citigroup

Clorox (NYSE:CLX) had its price objective trimmed by Citigroup from $130.00 to $120.00 in a research report report published on Tuesday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other equities analysts have also commented on the stock. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday. Wells Fargo & Company decreased their price target on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday. TD Cowen decreased their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. Bank of America decreased their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $152.00 price objective on shares of Clorox in a research note on Tuesday. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $127.60.

Clorox Price Performance

Shares of NYSE:CLX opened at $110.41 on Tuesday. The company’s fifty day moving average price is $120.13 and its 200-day moving average price is $125.40. The firm has a market capitalization of $13.44 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 0.92 and a beta of 0.52. Clorox has a one year low of $107.71 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s revenue for the quarter was down 18.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts anticipate that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.5%. Clorox’s dividend payout ratio is presently 76.07%.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.63% of the stock is owned by insiders.

Institutional Investors Weigh In On Clorox

Several institutional investors have recently added to or reduced their stakes in the company. Ashton Thomas Private Wealth LLC boosted its position in Clorox by 312.8% during the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 37,980 shares of the company’s stock valued at $4,683,000 after buying an additional 28,779 shares during the period. Mission Wealth Management LP boosted its position in Clorox by 5.8% during the 3rd quarter. Mission Wealth Management LP now owns 7,206 shares of the company’s stock valued at $889,000 after buying an additional 395 shares during the period. Atlantic Union Bankshares Corp boosted its position in Clorox by 3.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 6,893 shares of the company’s stock valued at $850,000 after buying an additional 200 shares during the period. Jones Financial Companies Lllp boosted its position in Clorox by 23.7% during the 3rd quarter. Jones Financial Companies Lllp now owns 17,735 shares of the company’s stock valued at $2,205,000 after buying an additional 3,398 shares during the period. Finally, Yacktman Asset Management LP boosted its position in Clorox by 30.5% during the 3rd quarter. Yacktman Asset Management LP now owns 58,995 shares of the company’s stock valued at $7,274,000 after buying an additional 13,785 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.